| Unique ID issued by UMIN | UMIN000062236 |
|---|---|
| Receipt number | R000071188 |
| Scientific Title | A prospective observational study of continuous monitoring of respiratory patterns and sleep-disordered breathing using millimeter-wave radar in patients with cardiovascular diseases |
| Date of disclosure of the study information | 2026/07/17 |
| Last modified on | 2026/07/15 14:15:03 |
A study using non-contact millimeter-wave radar to continuously assess respiratory patterns in patients with cardiovascular diseases and patients newly starting CPAP therapy
MWR Respiratory Monitoring Study
A prospective observational study of continuous monitoring of respiratory patterns and sleep-disordered breathing using millimeter-wave radar in patients with cardiovascular diseases
MWR-CARDIO Study
| Japan |
Cardiovascular diseases and sleep apnea syndrome
The cardiovascular conditions include angina pectoris or arrhythmia requiring elective percutaneous coronary intervention or catheter ablation, acute heart failure, and acute coronary syndrome. Patients with moderate-to-severe sleep apnea syndrome who are newly initiating continuous positive airway pressure therapy are also included.
| Cardiology | Pneumology |
Others
NO
Respiratory rate and respiratory patterns are important physiological parameters that reflect changes in the clinical condition of patients with cardiovascular diseases. However, continuous and objective assessment, especially during sleep, remains difficult in routine clinical practice.
Millimeter-wave radar (MWR) enables non-contact and unconstrained monitoring of respiratory activity by detecting subtle body surface movements without attaching sensors.
The primary objective of this prospective observational study is to evaluate the agreement between respiratory parameters measured using MWR, including respiratory rate, sleep apnea and hypopnea events, and periodic breathing, and those obtained using conventional monitoring methods in routine clinical practice. Study participants include patients undergoing elective percutaneous coronary intervention or catheter ablation, patients hospitalized for acute heart failure or acute coronary syndrome, and patients newly initiating continuous positive airway pressure (CPAP) therapy.
Secondary objectives are to investigate longitudinal changes in respiratory patterns before and after treatment, during the transition from the acute phase to the recovery phase, before and after cardiac rehabilitation, and their associations with clinical deterioration, treatment response, and recurrent cardiovascular events. In patients newly initiating CPAP therapy, the occurrence and longitudinal course of central sleep apnea, treatment-emergent central sleep apnea, and periodic breathing will also be explored.
No treatment modification, CPAP setting adjustment, or other research-specific intervention will be performed based on MWR measurements.
Others
Assessment of agreement between a non-contact respiratory monitoring device and conventional assessment methods, and exploratory evaluation of associations between longitudinal respiratory pattern changes and clinical outcomes
Exploratory
Others
Not applicable
Agreement between respiratory parameters measured using conventional monitors or assessment methods and those measured using millimeter-wave radar (MWR).
The main respiratory parameters evaluated will include:
Respiratory rate
Number or index of sleep apnea and hypopnea events
Periodic breathing variation
Conventional assessment methods will include visual observation, bedside monitors, pulse oximetry, portable sleep apnea monitoring, or polysomnography used as part of routine clinical care.
Agreement between measurement methods will be evaluated using correlation coefficients, mean differences and 95% limits of agreement obtained from Bland-Altman analysis, and intraclass correlation coefficients where appropriate.
1. Association between changes in respiratory patterns and clinical deterioration or improvement.
2. Changes in respiratory rate, sleep apnea and hypopnea events, and periodic breathing before and after elective percutaneous coronary intervention or catheter ablation.
3. Changes in respiratory patterns before and after cardiac rehabilitation.
4. Associations between respiratory patterns and clinical events, including worsening heart failure, rehospitalization, and recurrence of atrial fibrillation.
5. Continuous changes in respiratory patterns from the acute phase to the recovery phase in patients with acute heart failure or acute coronary syndrome.
6. Associations of respiratory rate, sleep apnea and hypopnea events, and periodic breathing measured using MWR with blood pressure, pulse rate, oxygen saturation, body temperature, physical findings, blood test results, electrocardiographic findings, echocardiographic findings, sleep study results, and clinical course.
7. Incidence of central sleep apnea or periodic breathing in patients newly initiating CPAP therapy.
8. Longitudinal changes in the central apnea index, residual apnea-hypopnea index, oxygen saturation variation, and respiratory patterns in patients newly initiating CPAP therapy.
9. Associations between respiratory patterns and CPAP usage parameters, including usage time, air leakage, and prescribed pressure.
10. Comparison of age, body mass index, baseline apnea-hypopnea index, presence of cardiovascular diseases, and CPAP usage parameters between patients with and without treatment-emergent central sleep apnea.
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Age 18 years or older.
2. Patients scheduled to undergo elective percutaneous coronary intervention or catheter ablation for angina pectoris or cardiac arrhythmias.
3. Patients hospitalized for acute heart failure or acute coronary syndrome.
4. Patients scheduled to initiate CPAP therapy for sleep apnea syndrome.
5. Patients who provide written informed consent after receiving a full explanation of the study.
1. Pregnant women or women with possible pregnancy.
2. Patients who refuse study participation or MWR monitoring.
3. Patients considered unsuitable for study participation by the principal investigator.
90
| 1st name | Hiroyuki |
| Middle name | |
| Last name | Takenaka |
Hirakata Kohsai Hospital, Federation of National Public Service Personnel Mutual Aid Associations
Department of Cardiology
573-0153
1-2-1 Fujisaka Higashimachi, Hirakata, Osaka, Japan
072-858-8233
h-takenaka@kkr-hirakoh.jp
| 1st name | Mitsunori |
| Middle name | |
| Last name | Miho |
Hirakata Kohsai Hospital, Federation of National Public Service Personnel Mutual Aid Associations
Department of Cardiology
573-0153
1-2-1 Fujisaka Higashimachi, Hirakata, Osaka, Japan
072-858-8233
m-miho@kkr-hirakoh.jp
Hirakata Kosei Hospital, Federation of National Public Service Personnel Mutual Aid Associations
MaRI Co., Ltd.
Profit organization
Hirakata Kosei Hospital, Federation of National Public Service Personnel Mutual Aid Associations
1-2-1 Fujisaka Higashimachi, Hirakata, Osaka, Japan
072-858-8233
m-miho@kkr-hirakoh.jp
NO
国家公務員共済組合連合会 枚方公済病院
| 2026 | Year | 07 | Month | 17 | Day |
Unpublished
Preinitiation
| 2026 | Year | 08 | Month | 01 | Day |
| 2026 | Year | 08 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
Millimeter-wave radar (MWR) will be installed in the patient's room or examination room to continuously monitor respiratory activity without attaching any sensors to the patient.
MWR measurements will be performed in parallel with routine clinical care. No additional treatment or modification of clinical management will be performed for research purposes.
Respiratory rate, sleep apnea and hypopnea events, and periodic breathing measured by MWR will be compared with conventional assessment methods used in routine clinical practice, including bedside monitors, pulse oximetry, and sleep studies.
Patients undergoing elective PCI or catheter ablation will be evaluated before and after treatment. Patients with acute heart failure or acute coronary syndrome will be followed from the acute phase to the recovery phase. Patients newly initiating CPAP therapy will undergo longitudinal assessment during the early treatment period.
Exploratory analyses will be performed to evaluate the associations between respiratory patterns and clinical findings, laboratory data, imaging results, and CPAP usage parameters.
| 2026 | Year | 07 | Month | 14 | Day |
| 2026 | Year | 07 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071188